The global effect of the COVID-19 pandemic on STEMI care: a systematic review and meta-analysis

NWS Chew, ZGW Ow, VXY Teo, RRY Heng… - Canadian Journal of …, 2021 - Elsevier
Background The COVID-19 pandemic has affected patients with ST-segment elevation
myocardial infarction (STEMI) requiring primary percutaneous coronary intervention (PCI) …

Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes: insights from the Rapamycin-Eluting Stent Evaluated At Rotterdam …

PA Lemos, C Lee, M Degertekin, F Saia… - Journal of the American …, 2003 - jacc.org
Objectives: This study evaluated the early outcomes of patients with acute coronary
syndromes (ACS) treated with sirolimus-eluting stents (SES). Background: The safety of SES …

Effects of sodium/glucose cotransporter 2 (SGLT2) inhibitors on cardiovascular and metabolic outcomes in patients without diabetes mellitus: a systematic review and …

YH Teo, YN Teo, NL Syn, CS Kow… - Journal of the …, 2021 - Am Heart Assoc
Background Recent studies have increasingly shown that sodium‐glucose cotransporter 2
(SGLT2) inhibitors may have beneficial cardiovascular and metabolic effects in patients …

Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up

PC Smits, RJM van Geuns, D Poldermans… - Journal of the American …, 2003 - jacc.org
Objectives: We report on the procedural and six-month results of the first percutaneous and
stand-alone study on myocardial repair with autologous skeletal myoblasts. Background …

Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial

J Kay, WH Chow, TM Chan, SK Lo, OH Kwok, A Yip… - Jama, 2003 - jamanetwork.com
Context The antioxidant acetylcysteine prevents acute contrast nephrotoxicity in patients
with impaired renal function who undergo computed tomography scanning. However, its role …

Obstructive sleep apnea and cardiovascular events after percutaneous coronary intervention

CH Lee, R Sethi, R Li, HH Ho, T Hein, MH Jim, G Loo… - Circulation, 2016 - Am Heart Assoc
Background—There is a paucity of data from large cohort studies examining the prognostic
significance of obstructive sleep apnea (OSA) in patients with coronary artery disease. We …

Obstructive sleep apnea in patients admitted for acute myocardial infarction: prevalence, predictors, and effect on microvascular perfusion

CH Lee, SM Khoo, BC Tai, EY Chong, C Lau, Y Than… - Chest, 2009 - Elsevier
Background We investigated the prevalence and predictors of obstructive sleep apnea in
patients admitted to the hospital for acute myocardial infarction and whether OSA has any …

Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score …

S Brugaletta, T Gori, AF Low, P Tousek, E Pinar… - JACC: Cardiovascular …, 2015 - jacc.org
Objectives: The purpose of this study was to compare the 1-year outcome between
bioresorbable vascular scaffold (BVS) and everolimus-eluting metallic stent (EES) in ST …

Severe obstructive sleep apnea and outcomes following myocardial infarction

CH Lee, SM Khoo, MY Chan, HB Wong… - Journal of Clinical …, 2011 - jcsm.aasm.org
Study Objective: We sought to determine the effect of severe obstructive sleep apnea (OSA)
on long-term outcomes after myocardial infarction. We hypothesized that severe OSA was …

Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis

M Degertekin, PW Serruys, K Tanabe, CH Lee… - Circulation, 2003 - Am Heart Assoc
Background—Incomplete stent apposition (ISA) has been previously documented after
sirolimus-eluting stent (SES) implantation. The aim of this study was to investigate the long …